Literature DB >> 10604879

Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase.

R A Zakharyan1, H V Aposhian.   

Abstract

A unique enzyme, MMA(V) reductase, has been partially purified from rabbit liver by using DEAE-cellulose, carboxymethylcellulose, and red dye ligand chromatography. The enzyme is unique since it is the rate-limiting enzyme in the biotransformation of inorganic arsenite in rabbit liver. The K(m) and V(max) values were 2.16 x 10(-)(3) M and 10.3 micromol h(-)(1) (mg of protein)(-)(1). When DMA(V) or arsenate was tested as a substrate, the K(m) was 20.9 x 10(-)(3) or 109 x 10(-)(3) M, respectively. The enzyme has an absolute requirement for GSH. Other thiols such as DTT or L-cysteine were inactive alone. At a pH below the physiological pH, GSH carried out this reduction, but this GSH reduction in the absence of the enzyme had little if any value at pH 7.4. When the K(m) values of rabbit liver arsenite methyltransferase (5.5 x 10(-)(6) M) and MMA(III) methyltransferase (9.2 x 10(-)(6)) were compared to that of MMA(V) reductase (2.16 x 10(-)(3) M), it can be concluded that MMA(V) reductase was the rate-limiting enzyme of inorganic arsenite biotransformation. MMA(V) reductase was also present in surgically removed human liver.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604879     DOI: 10.1021/tx9901231

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  14 in total

Review 1.  Microbial methylation of metalloids: arsenic, antimony, and bismuth.

Authors:  Ronald Bentley; Thomas G Chasteen
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

2.  Monomethylarsonous acid induces transformation of human bladder cells.

Authors:  Tiffany G Bredfeldt; Bhumasamudram Jagadish; Kylee E Eblin; Eugene A Mash; A Jay Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2006-06-27       Impact factor: 4.219

3.  Tissue dosimetry, metabolism and excretion of pentavalent and trivalent monomethylated arsenic in mice after oral administration.

Authors:  Michael F Hughes; Vicenta Devesa; Blakely M Adair; Miroslav Styblo; Elaina M Kenyon; David J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2005-10-15       Impact factor: 4.219

4.  GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh.

Authors:  Ema G Rodrigues; Molly Kile; Elaine Hoffman; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Yumei Hsueh; David C Christiani
Journal:  Biomarkers       Date:  2012-02-18       Impact factor: 2.658

5.  shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells.

Authors:  Zuzana Drobna; Weibing Xing; David J Thomas; Miroslav Stýblo
Journal:  Chem Res Toxicol       Date:  2006-07       Impact factor: 3.739

6.  Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase.

Authors:  Zuzana Drobná; Stephen B Waters; Vicenta Devesa; Anne W Harmon; David J Thomas; Miroslav Stýblo
Journal:  Toxicol Appl Pharmacol       Date:  2005-09-01       Impact factor: 4.219

7.  Speciation, formation, stability and analytical challenges of human arsenic metabolites.

Authors:  Lucy Yehiayan; Mahesh Pattabiraman; Konstantinos Kavallieratos; Xiaotang Wang; Lawrence H Boise; Yong Cai
Journal:  J Anal At Spectrom       Date:  2009-07-21       Impact factor: 4.023

8.  Influence of GSTT1 Genetic Polymorphisms on Arsenic Metabolism.

Authors:  Molly L Kile; E Andres Houseman; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Golam Mostofa; Yu-Mei Hsueh; David C Christiani
Journal:  J Indian Soc Agric Stat       Date:  2013-08-01

9.  Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites.

Authors:  Hisham A El-Masri; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-10-18       Impact factor: 2.745

Review 10.  Origins, fate, and actions of methylated trivalent metabolites of inorganic arsenic: progress and prospects.

Authors:  Miroslav Stýblo; Abhishek Venkatratnam; Rebecca C Fry; David J Thomas
Journal:  Arch Toxicol       Date:  2021-03-26       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.